PIB Headquarters
PIB’S BULLETIN ON COVID-19
|
|
- 57.61 Cr. vaccine doses have been administered so far under Nationwide Vaccination Drive
- 34,457 new cases in the last 24 hours
- Active cases account for 1.12% of total cases; lowest since March 2020
- India's Active caseload stands at 3,61,340; lowest in 151 days
- Recovery Rate increases to 97.54%; Highest since March 2020
- 36,347 recoveries in the last 24 hours increases Total Recoveries to 3,15,97,982
- Weekly Positivity Rate  less than 3% for last 57 days
- Daily positivity rate  less than 3% for last 26 days
- 50.45 crore Total Tests conducted so far
#Unite2FightCorona#IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
COVID-19 Update
India’s Cumulative COVID-19 Vaccination Coverage exceeds 57.61 Cr
Recovery Rate  at its highest since March 2020
34,457 New Cases reported in the last 24 hours
India's Active Caseload  lowest in 151 days
Active cases constitute 1.12% of total cases; lowest since March 2020
Daily Positivity Rate  less than 3% for last 26 days
With the administration of 36,36,043 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has surpassed the cumulative figure of 57.61 Cr  as per provisional reports till 7 am today. This has been achieved through 64,01,385 sessions.
The break-up of the cumulative figure as per the provisional report till 7 am today include:
|
|
HCWs
|
|
1st Dose
|
|
1,03,52,796
|
|
2nd Dose
|
|
81,87,062
|
|
FLWs
|
|
1st Dose
|
|
1,82,99,850
|
|
2nd Dose
|
|
1,24,76,020
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
21,37,85,511
|
|
2nd Dose
|
|
1,84,75,457
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
12,18,54,173
|
|
2nd Dose
|
|
4,80,82,007
|
|
Over 60 years
|
|
1st Dose
|
|
8,30,11,132
|
|
2nd Dose
|
|
4,15,93,342
|
|
Total
|
|
57,61,17,350
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
The recovery of 36,347 patients in the last 24 hours has increased the cumulative tally of recovered patients  to 3,15,97,982.
Consequently, India’s recovery rate stands at 97.54%, the highest since March 2020.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for fifty-five consecutive days now.
34,457 new cases were reported in the last 24 hours.
High recoveries and a low number of new cases have subsided the Active Caseload to 3,61,340 which is at its lowest in 151 days. Active cases presently form only 1.12% of the country's total Positive Cases which is the lowest since March 2020.
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1747745
National Institute of Animal Biotechnology, Hyderabad notified as Central Drugs Laboratory for testing and batch release of vaccines
Department of Biotechnology, Ministry of S&T, is committed to Scaling up the Vaccine Development and Manufacturing Ecosystem
In public interest it is necessary to establish more facilities to regulate the testing of COVID-19 vaccines for quick release of vaccine batches for prevention and treatment of COVID-19 infection. Considering this requirement, the Government of India has identified two Autonomous Institutes of the Department of Biotechnology , viz., National Institute of Animal Biotechnology , Hyderabad and National Centre for Cell Science , Pune, for upgradation as Central Drug Laboratories . The funding support for the same was provided under the PM-CARES funds.
The Department of Biotechnology, Ministry of Science and Technology, Government of India, continues its support to scale up the vaccine development and manufacturing ecosystem. The setting up of facilities for vaccine testing at NCCS, Pune and NIAB, Hyderabad, is a step in this direction.
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1747821
The approval for world’s first DNA based ‘ZyCov-D’ vaccine of Zydus Universe is a testimony to the innovative zeal of India’s scientists: PM
The Prime Minister, Shri Narendra Modi has said that the approval for world’s first DNA based ‘ZyCov-D’ vaccine of Zydus Universe is a testimony to the innovative zeal of India’s scientists.
In response to a tweet by CDSCO India Info, the Prime Minister said;
"India is fighting COVID-19 with full vigour. The approval for world’s first DNA based ‘ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists. A momentous feat indeed."
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1747726
Important Tweets